Brief: Spineguard Seeks FDA Approval To Commercialise DSG Connect

Spineguard SA

04/06/2020 17:07

June 4 (Reuters) - Spineguard SA  ALSGD.PA :
    * FILES ITS “510K” DOSSIER FOR THE CLEARANCE OF ITS NEW “DSG
CONNECT” PLATFORM IN THE UNITED STATES
    * COMMERCIALIZATION IN UNITED STATES WILL COMMENCE AS SOON
AS FILE
IS VALIDATED, WHICH USUALLY TAKES 3 TO 9 MONTHS

Source text for Eikon:  ID:nBwbNkxk1a 
Further company coverage:  ALSGD.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))